EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Branched Chain Amino Acid Metabolism in Developmental Brain Injury: Putative Mechanisms and Therapeutic Potential

Margaret M Cassidy, Marc Yudkoff, Rebecca C Ahrens-Nicklas, Ana G Cristancho

Developmental Neuroscience · 11.03.2025 · 48 (1) · 68-82

DOI: 10.1159/000545099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Developmental Neuroscience, online erschienen am 11.03.2025. Verfasst von Margaret M Cassidy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell and Molecular Biology PhD Program, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Amino Acids, Branched-Chain, Fetal Hypoxia, Prenatal Injuries, Brain Injuries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Branched chain amino acid (BCAA) metabolism plays roles in various cellular processes, including energy homeostasis, anabolic signaling, and production of glutamate, the primary excitatory neurotransmitter. Emerging evidence also suggests BCAA metabolism has relationships to inflammatory and hypoxic cellular responses. Recent work in adult and adolescent clinical populations has suggested that BCAA dietary supplementation may improve outcomes associated with traumatic brain injury. Given these links, examining the putative mechanisms and potential therapeutic applications of modulating dietary BCAA content in the context of inflammatory and hypoxic developmental brain injury may reveal mechanisms for intervention in affected infants. Summary: Inflammatory and hypoxic brain injuries influence the dynamics of BCAA metabolism in the fetal brain. Inflammatory insults to the developing brain may increase BCAA catabolism downstream of the branched chain ketoacids (BCKAs). The effect of altered BCAA metabolism on the pathophysiology of inflammatory developmental brain injury is currently unclear but may play a role in microglial response. Hypoxic brain injury seems to increase BCAA concentration in the fetal brain, possibly because of re-amination of BCKAs to the parent BCAAs, or via increased protein breakdown during hypoxia. Key Messages: The apparent relationship between aberrant BCAA metabolism and inflammation or hypoxia warrants consideration of BCAA supplementation or restriction as a strategy for attenuating developmental brain injury that is associated with these pathologic events. This approach could entail alterations of maternal diet during pregnancy or the feeding of infant formula that is fortified with or restricted in BCAA. These types of interventions have been safely and effectively employed in cases of inborn errors of BCAA metabolism, suggesting feasibility in infant populations. Both in vitro and preclinical work is necessary to elucidate how BCAA supplementation or restriction may affect the sequelae of inflammatory and hypoxic developmental brain injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acids, Branched-ChainFetal HypoxiaPrenatal InjuriesBrain InjuriesBrainHumansAnimalsMice

Stichwörter der Autor:innen

Branched chain amino acid metabolismDevelopmental brain injuryHypoxiaInflammation

Substanzen

Amino Acids, Branched-Chain

Autor:innen und Institutionen

  • Cell and Molecular Biology PhD Program, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Metabolomics, Mitochondrial Frontier Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA, ahrensnicklasr@chop.edu.

Förderung

  • NINDS NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Cassidy, M. M., Yudkoff, M., Ahrens-Nicklas, R. C., & Cristancho, A. G. (2025). Branched Chain Amino Acid Metabolism in Developmental Brain Injury: Putative Mechanisms and Therapeutic Potential. Developmental Neuroscience, 48(1), 68-82. https://doi.org/10.1159/000545099

Vancouver

Cassidy MM, Yudkoff M, Ahrens-Nicklas RC, Cristancho AG. Branched Chain Amino Acid Metabolism in Developmental Brain Injury: Putative Mechanisms and Therapeutic Potential. Developmental Neuroscience. 2025;48(1):68-82. doi:10.1159/000545099

BibTeX
@article{Cassidy2025,
  author = {Cassidy, Margaret M and Yudkoff, Marc and Ahrens-Nicklas, Rebecca C and Cristancho, Ana G},
  title = {Branched Chain Amino Acid Metabolism in Developmental Brain Injury: Putative Mechanisms and Therapeutic Potential},
  journal = {Developmental Neuroscience},
  year = {2025},
  volume = {48},
  number = {1},
  pages = {68--82},
  doi = {10.1159/000545099}
}
Kostenlos starten →